34 reports

Current and Emerging Products - Analysis of current and emerging blood typing, grouping and infectious disease NAT screening assays

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.

  • Infectious Disease
  • Pathology
  • Brazil
  • Market Size

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.

  • Infectious Disease
  • Pathology
  • Brazil
  • Market Size

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.

  • Infectious Disease
  • Pathology
  • Brazil
  • Market Size
  • Infectious Disease Market, Brazil
  • Infectious Disease Market, Brazil, Segment Contribution (%), 2018

Table ##: Infectious Disease Market, Brazil, Segment Contribution (%), 2018 ##. ## INFECTIOUS DISEASE MARKET, BRAZIL, REVENUE ($M), 2015-2025 Figure ##: Infectious Disease Market, Brazil, Revenue ($m), USD Constant, 2015-2025 Table ##:

  • Infectious Disease
  • Brazil
  • Market Size
  • Abbott Laboratories, Inc.
  • Danaher Corporation

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

BMC INFECTIOUS DISEASES, ##(##), P. ##.

  • Infectious Disease
  • Brazil
  • East Asia
  • Sanofi S.A.
  • Seqirus UK Limited

BIOMERIEUX PRODUCTS ARE USED DIAGNOSING AND MANAGING INFECTIOUS DISEASES, CARDIOVASCULAR DISEASES AND TARGETED CANCERS.

  • Infectious Disease
  • Brazil
  • Alere Inc.
  • bioMerieux S.A.
  • Hologic, Inc.
  • BECTON, DICKINSON AND COMPANY SUMMARY
  • ALERE

The initial screening of infectious diseases has created a growing opportunity for POC infectious disease tests, which are currently worth roughly $## million.

  • Infectious Disease
  • Brazil
  • Alere Inc.
  • Becton Property Group
  • bioMerieux S.A.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.

  • Infectious Disease
  • Pathology
  • Brazil
  • Market Size

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.

  • Infectious Disease
  • Pathology
  • Brazil
  • Market Size

Current and Emerging Products - Analysis of current and emerging blood typing, grouping and infectious disease NAT screening assays

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil
  • Forecast

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Hepatitis
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

BIOMERIEUX PRODUCTS ARE USED DIAGNOSING AND MANAGING INFECTIOUS DISEASES, CARDIOVASCULAR DISEASES AND TARGETED CANCERS.

  • Infectious Disease
  • Brazil
  • Forecast
  • Market Size
  • QIAGEN N.V.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.

  • Infectious Disease
  • Pathology
  • Brazil
  • Market Size

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Hepatitis
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

Market Segmentation Analysis - Volume and sales forecasts for over ## infectious disease assays by individual test

  • Infectious Disease
  • Pathology
  • Brazil

Market Segmentation Analysis - Volume and sales forecasts for over ## infectious disease assays by individual test

  • Infectious Disease
  • Pathology
  • Brazil

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Hepatitis
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

Market Segmentation Analysis - Volume and sales forecasts for over ## infectious disease assays by individual test. - Test volume estimates by method (molecular, serology/ immunodiagnostics, culture/ microscopy).

  • Infectious Disease
  • Pathology
  • Brazil

Market Segmentation Analysis - Volume and sales forecasts for over ## infectious disease assays by individual test. - Test volume estimates by method (molecular, serology/ immunodiagnostics, culture/ microscopy).

  • Infectious Disease
  • Pathology
  • Brazil
  • MERCK'S HCV PORTFOLIO ASSESSMENT, 2016
  • HIGHLIGHTS MERCK'S PORTFOLIO OF MARKETED AND PIPELINE PRODUCTS INDICATED FOR HCV.

CLINICAL INFECTIOUS DISEASES; ##(##): ##-##.

  • Infectious Disease
  • Brazil
  • Market Size
  • AbbVie Inc.
  • Gilead Sciences, Inc.

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

High prevalence of endemic infectious disease along with positive potential for emergence of new diseases like Ebola make infectious disease testing another segment of prime activity in Latin America point of care market.

  • Infectious Disease
  • Pathology
  • Point Of Care Testing
  • Brazil
  • Forecast

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY; ##(##): ##-##.

  • Infectious Disease
  • Brazil
  • Western Europe
  • Market Size
  • Novartis AG

Brazilian Journal of Infectious Diseases; ##(##): ##-##.

  • Hepatitis
  • Infectious Disease
  • Pathology
  • Brazil
  • Forecast

The pharmaceutical segment produces and markets products in five therapeutic areas, including immunology (rheumatoid arthritis, inflammatory bowel disease, psoriasis and pulmonary diseases), infectious diseases (human immunodeficiency virus (HIV), hepatitis, respi

  • Infectious Disease
  • Therapy
  • Brazil
  • GlaxoSmithKline plc
  • Johnson & Johnson